Mandates Ryoncil® CoverageNEW YORK, March 30, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that ...

The Harrison County Genealogical Society, along with the Clarksburg History Museum, is offering county high school seniors ...

Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.

Using an unbiased approach, this important study discovered a role of Ezh2 in the differentiation of granule neuron precursors, the cell of origin for Shh group of medulloblastoma. Furthermore, the ...

RIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. We believe that obexelimab's unique ...

Stem Cell Coin (SCC) is a digital asset with a market capitalization of $0.00. Stem Cell Coin is ranked as number in the global cryptocurrency rating with a 24-hour trading volume of $0.02. Currently, ...

According to Tuesday’s Job Openings and Labor Turnover Survey (JOLTS) from the US Bureau of Labor Statistics (BLS), job openings totaled 7.74 million at the end of January. This figure, which ...

At this time, I would like to welcome everyone to the Lineage Cell Therapeutics Fourth Quarter and Full Year 2024 Conference Call. At this time, all participants are in a listen only mode.

Lineage Cell (LCTX) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.03 per share a year ago. These figures are ...

CARLSBAD, Calif.--(BUSINESS WIRE)--$LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology ...